Amalgamation/Merger

August 5, 2026 To To Listing Department, The Corporate Relations Department NATIONAL STOCK EXCHANGE OF INDIA LIMITED BSE LIMITED Exchange Plaza, Bandra Kurla Complex, Bandra (E), Phiroz Jeejeebhoy Towers, 25th floor, Dalal Street, MUMBAI -400 051 MUMBAI -400 001 Company Code No. AUROPHARMA Company Code No. 524804 Dear Sir / Madam, Sub: Proposal of merger of the step-down subsidiaries with wholly owned subsidiary of the Company We would like to inform you that a proposal to file a Scheme of Amalgamation for merger of Eugia Steriles Private Limited and Eugia SEZ Private Limited, two step-down wholly owned subsidiaries of the Company, with Eugia Pharma Specialities Limited, a wholly owned subsidiary of the Company, with Hon’ble NCLT, Hyderabad, has been approved by the Board of Directors of the respective companies and also the Company. The disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Part A of Schedule III of the aforesaid regulations, is attached as Annexure. The Board meeting commenced at 4:00 p.m. and concluded at 6.30 p.m. Please take the information on record. Thanking you, Yours faithfully, For AUROBINDO PHARMA LIMITED B. Adi Reddy Company Secretary Encl.: Annexure Corp. Off.: Galaxy, Floors: 22-24, Plot No.1, Survey No.83/1, Hyderabad Knowledge City, Raidurg Panmaktha, Ranga Reddy District, Hyderabad – 500 032, Telangana, India. Tel : +91 40 6672 5000 / 6672 1200 Fax: +91 40 6707 4044. Regd. off.: Plot No. 2, Maithrivihar, Ameerpet, Hyderabad - 500 038, Telangana, India Tel: +91 40 2373 6370/ 2374 7340 Fax: +91 40 2374 1080 / 2374 6833 Email: info@aurobindo.com Website: www.aurobindo.com Annexure a) Name of the entity(ies) forming part of Eugia Pharma Specialities Limited (Eugia Pharma), a wholly the amalgamation/merger, details in brief owned subsidiary of the Company, is the transferee company such as, size, turnover etc.; which was incorporated in India on April 17th, 2013. Eugia Steriles Private Limited (Eugia Steriles), a wholly owned stepdown subsidiary of the Company, is the transferor company 1, which was incorporated in India on July 5th, 2020. Eugia SEZ Private Limited (Eugia SEZ), a wholly owned step- down subsidiary of the Company, is the transferor company 2, which was incorporated in India on February 20th, 2021. All the above companies are engaged in manufacturing injectable pharmaceutical products. The turnover of Eugia Pharma, Eugia Steriles and Eugia SEZ for the financial year ended March 31st 2026 is as under: Name of the company Turnover for FY 2026 (INR million) Eugia Pharma 27,259.04 Eugia Steriles 62.7 Eugia SEZ 4,874.2 b) Whether the transaction would fall Yes, the transaction is between two step-down subsidiaries and within related party transactions? If yes, a wholly owned subsidiary of the Company. As per the whether the same is done at “arm’s provisions of Section 188 of Companies Act, 2013 and length”; Regulation 23(5)(b) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, provisions relating to related party transactions are not applicable in respect of transactions among wholly owned subsidiaries and their holding Company. c) Area of business of the entity(ies); All three companies are engaged in the business of manufacturing injectable pharmaceutical products. d) Rationale for amalgamation/ merger The proposed amalgamation will simplify the existing group structure by consolidating three companies carrying on substantially similar businesses into a single legal entity. The amalgamation shall lead to elimination of corporate and administrative functions and overheads, cost reduction, better treasury management, synergy benefits etc. e) In case of cash consideration – amount No consideration since the proposed merger is between two or otherwise share exchange ratio; wholly owned subsidiaries and their holding company. f) Brief details of change in shareholding Not applicable. pattern (if any) of listed entity. The Company is not a party to the Scheme of Amalgamation and the shareholding pattern of the Company remains unchanged. Corp. Off.: Galaxy, Floors: 22-24, Plot No.1, Survey No.83/1, Hyderabad Knowledge City, Raidurg Panmaktha, Ranga Reddy District, Hyderabad – 500 032, Telangana, India. Tel : +91 40 6672 5000 / 6672 1200 Fax: +91 40 6707 4044. Regd. off.: Plot No. 2, Maithrivihar, Ameerpet, Hyderabad - 500 038, Telangana, India Tel: +91 40 2373 6370/ 2374 7340 Fax: +91 40 2374 1080 / 2374 6833 Email: info@aurobindo.com Website: www.aurobindo.com